JSE-listed pharmaceutical companies are gearing up to bid for the Department of Health’s latest AIDS-drug tender, which manufacturers estimate to be worth between R6bn and R9.5bn...The two-year tender potentially offers good news for businesses and patients with new measures that give preference to local manufacturers and a commitment to providing patients with three-in-one pills that have until now been unavailable in the state sector...Doctors Without Borders’ (MSF) head of advocacy Donela Besada welcomed the government’s decision to provide fixed-dose combination pills...

Read article below.